BAYRY
+0.4% on Oct 16
Updated Oct 17 · 5 feeds behind: FDA drug approvals, 1 day, and 4 more · Every feed →
On this page
The market view
Price chart
The interactive BAYRY chart (by TradingView) loads here.
Our take
2 rules fired on BAYRY
In short: none of these rules has solid or some evidence yet, so they show no clear lean on BAYRY.
How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.
- 3+ FDA approvals while markets are jumpy Approvals Through the Chaos⚪ Not enough evidence · +8.6 pp vs similar · 6 signals on BAYRY
- Buy when a major drug trial completes Buy Drugmakers When a Major Drug Trial Finishes⚪ Not enough evidence · +2.5 pp vs similar · 4 signals on BAYRY
Is disclosure activity unusual?
No insider or Congress trades of BAYRY are on file, so there is no history to compare. Missing records do not mean no one traded.
Company timeline
What has been happening?
May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.
FDA & trials
FDA & trials · May 2026
3 on file. This page lists only the newest records.
FDA & trials · Jun 2026
4 on file. This page lists only the newest records.
FDA & trials · Jul 2026
8 on file. This page lists only the newest records.
FDA & trials · Aug 2026
3 on file. This page lists only the newest records.
FDA & trials · Sep 2026
- Record date
- Record date FDA approval: Claritin ↗
NDA · supplement
- Record date
- Record date FDA approval: Nda212099 ↗
NDA · supplement
- Record date FDA approval: Nda215341 ↗
NDA · supplement
2 more on file are not listed here.
All 5 records in this snapshot
- Record date
- Record date FDA approval: Claritin ↗
NDA · supplement
- Record date
- Record date FDA approval: Nda212099 ↗
NDA · supplement
- Record date FDA approval: Nda215341 ↗
NDA · supplement
Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.
Who's buying and selling · last 90 days
Congress
No Congress trades on BAYRY disclosed in the last 90 days.
See every Congress trade on BAYRY →Company insiders
No insider buys or sells of BAYRY filed in the last 90 days.
See every insider trade on BAYRY →Filings & events
FDA and clinical trials 111
Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.
- Sep 29, 2026Clinical trial completed: Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer ↗Phase 3
- Sep 25, 2026FDA approval: Claritin ↗NDA · supplement
- Sep 23, 2026Clinical trial completed: Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle" ↗Phase 1
- Sep 22, 2026FDA approval: Nda212099 ↗NDA · supplement
- Sep 16, 2026FDA approval: Nda215341 ↗NDA · supplement
Biggest named funds (13F)
The largest BAYRY holdings among the well-known funds whose quarterly 13F filings we read — opens here.
Every disclosed trade on BAYRY
No disclosed trades on BAYRY yet — the feeds fill in at the next data publish.
See the trades on BAYRY in the feed →People & votes
Which members of Congress traded BAYRY, sponsored bills that touch it and voted on them — opens here.